New treatments for Huntington’s disease [ 2017 - ]

Research Grant

Researchers: Dr Thibault Renoir (Principal investigator) ,  Dr Scott Ayton ,  Prof Anthony Hannan

Brief description Huntington’s disease (HD) is a devastating neurodegenerative disorder which shares several features with Alzheimer’s and Parkinson’s disease (i.e. dementia-like cognitive deficits). There is currently no cure for HD. Using a mouse model of HD and a combination of relevant drugs (i.e. N-Acetylcysteine and deferiprone) targeting two distinct levels of the cascade of events leading to HD, we will slow down the progression of the disease and correct dysfunctions within the brain.

Funding Amount $674,034.00

Funding Scheme Project Grants

Notes Standard Project Grant